Christian Leisner, CDR-Life CEO

RA, Jeito and Omega back a small Swiss biotech to en­ter an I/O field paved by Adap­ti­m­mune

A li­cens­ing deal worth up to $520 mil­lion has been fu­el­ing lit­tle-known Swiss biotech CDR-Life since May 2020, but the five-year-old start­up is ready to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA